Drug Shortage Report for MYLAN-BECLO AQ
| Report ID | 203100 |
| Drug Identification Number | 02172712 |
| Brand name | MYLAN-BECLO AQ |
| Common or Proper name | BECLOMETHASONE DIPROPIONATE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | BECLOMETHASONE DIPROPIONATE |
| Strength(s) | 50MCG |
| Dosage form(s) | SUSPENSION METERED-DOSE AEROSOL |
| Route of administration | NASAL NASAL |
| Packaging size | 22s |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-01-03 |
| Actual start date | 2023-01-03 |
| Estimated end date | 2024-02-21 |
| Actual end date | 2024-02-21 |
| Shortage status | Resolved |
| Updated date | 2024-02-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2024-02-29 | French | Compare |
| v17 | 2024-02-29 | English | Compare |
| v16 | 2024-02-21 | French | Compare |
| v15 | 2024-02-21 | English | Compare |
| v14 | 2024-02-15 | French | Compare |
| v13 | 2024-02-15 | English | Compare |
| v12 | 2024-01-19 | French | Compare |
| v11 | 2024-01-19 | English | Compare |
| v10 | 2024-01-10 | French | Compare |
| v9 | 2024-01-10 | English | Compare |
| v8 | 2023-12-19 | French | Compare |
| v7 | 2023-12-19 | English | Compare |
| v6 | 2023-11-28 | French | Compare |
| v5 | 2023-11-28 | English | Compare |
| v4 | 2023-10-26 | French | Compare |
| v3 | 2023-10-26 | English | Compare |
| v2 | 2023-08-29 | French | Compare |
| v1 | 2023-08-29 | English | Compare |
Showing 1 to 18 of 18